Levofloxacin-Resistant Pneumococcus
Open Access
- 1 August 2000
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 31 (2) , 626
Abstract
Sir—Wortmann and Bennett [1] report the isolation of Streptococcus pneumoniae from the blood and CSF of a patient who had received 4 days of levofloxacin therapy (500 mg orally once daily). In order to assess the likelihood that this might occur in the future, it is important to know the levofloxacin MIC of the pathogen. Pharmocodynamic principles would suggest that strains with levofloxacin MICs of 4–8 µg/mL would be unlikely to be eradicated by the dosage of levofloxacin they used. The authors described “a zone of inhibition of zero” determined by the E-test (AB Biodisk, Piscataway, NJ). The E-test gives a quantitative MIC and is not read in terms of a zone diameter. Could the authors clarify the MIC of the E-test? If indeed there was no inhibition at all around the E-test, are the authors suggesting that the MIC of this strain is ≥32µg/mL, which is the appropriate interpretation of a levofloxacin E-test with no zone of inhibition?Keywords
This publication has 6 references indexed in Scilit:
- A 5-Year Review of Recurrent Group B Streptococcal Disease: Lessons from Twin InfantsClinical Infectious Diseases, 2000
- Fatal Meningitis Due to Levofloxacin-Resistant Streptococcus pneumoniaeClinical Infectious Diseases, 1999
- Prosthetic hip-joint infection associated with a penicillin-tolerant group B streptococcusJournal of Infection, 1992
- Penicillin Tolerance in Group 8 Streptococci Isolated from Infected NeonatesThe Journal of Infectious Diseases, 1981
- pH-dependent penicillin tolerance of group B streptococciAntimicrobial Agents and Chemotherapy, 1981
- Bactericidal studies of penicillin-gentamicin combinations against group B streptococci.The Journal of Antibiotics, 1977